Consumer News Diabetes Patients Find It Harder To Fill Prescriptions For Insulin
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Diabetes Patients Find It Harder To Fill Prescriptions For Insulin is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Massachusetts nonprofit aims to make insulin more affordable for diabetes patients

A nonprofit in Cambridge, Massachusetts is aiming to make insulin more accessible for diabetes patients in the United States by selling vials of the drug at a fraction of the cost. According to WBZ-TV ... Read More
California To Launch Insulin for Just $11 a Pen
The state’s insulin — sold under the brand name CalRx — will be available at a recommended price of $11 per pen, or $55 for a five-pack. The move is part of a partnership between the state and the ... Read More
Novel Therapy Aims to Make Type 1 Diabetes Patients Insulin Free

UCSF Health transplant specialists recently performed an innovative, minimally invasive pancreatic islet transplant designed to enable a patient with Type 1 diabetes to become insulin independent. The ... Read More
California to begin selling affordable, state-branded insulin beginning next year
Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at ... Read More
A Cure for Type 1 Diabetes Seems Close, Thanks to New Drugs and Tech
Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in research, and a few therapies show signs of success. The progress has people ... Read More
Sanofi set to offer insulin products at $35 per month for all US patients

Sept 26 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Friday it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus